The U.S. neurological device market was valued at over $7.6 billion in 2024 and is projected to grow at a CAGR of 3.8%, reaching nearly $10 billion by 2031.
Market growth is driven by:
- Advancements in neuromodulation, brain-computer interfaces (BCIs), and AI-powered diagnostics.
- Increasing demand for minimally invasive neurovascular interventions.
- Expanded indications for neuromodulation in pain management and movement disorders.
The 2025 report suite covers:
- Cerebrospinal Fluid (CSF) Management
- Detachable Coil & Liquid Embolic Devices
- Neurovascular Catheters, Guidewires, Stents & Thrombectomy Devices
- Neuromodulation Devices & Intrathecal Pumps
- Stereotactic Devices, Neuroendoscopy & Ultrasonic Aspirators
Market Report Data Types Included
- Unit Sales & Average Selling Prices (ASP)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Analysis & Market Shares
- Recent Mergers & Acquisitions
- Company Profiles & Product Portfolios
- Leading Competitors
U.S. Neurological Device Market Insights
Neuromodulation Leads Market Growth:
- Spinal cord stimulation (SCS), deep brain stimulation (DBS), and sacral nerve stimulation (SNS) are key segments.
- Closed-loop and AI-driven neuromodulation systems are improving personalized treatment efficacy.
- Growing applications in psychiatric disorders and pain management are expanding the market.
Neurovascular Thrombectomy Sees Rapid Expansion:
- Advancements in aspiration catheters and stent retrievers enhance procedural efficiency.
- Increased adoption of thrombectomy in stroke centers improves acute stroke care.
- AI and real-time imaging integration are optimizing clot retrieval outcomes.
U.S. Neurological Device Market Share Insights (2024)
1 Medtronic - Market Leader
- Dominant in neuromodulation, liquid embolics, intrathecal pumps, and stereotactic devices.
- Faces increasing competition in sacral nerve stimulation from Axonics.
- January 2025: Medtronic earns CE Mark approval for BrainSense Adaptive DBS and Electrode Identifier, advancing BCI technology for Parkinson’s care.
2 Stryker - Second-Largest Competitor
- Strong performance in neurovascular guidewires, detachable coils, and ultrasonic aspirators.
- January 2025: Stryker announces definitive agreement to acquire Inari Medical, strengthening its neurovascular portfolio.
- Focuses on minimally invasive neurovascular solutions for thrombectomy and aneurysm repair.
3 Abbott - Third-Largest Competitor
- Significant presence in neuromodulation with its Infinity™ DBS system and BurstDR™ spinal cord stimulation.
- January 2025: Abbott announces long-term efficacy of BurstDR™ SCS in chronic pain treatment, with 91% of patients preferring it over traditional methods.
- Introduced NeuroSphere™ Digital Health app for remote patient management.
Market Segmentation Summary
Cerebrospinal Fluid (CSF) Market - Further segmented into:
- CSF Shunts
- CSF External Drainage Systems
Detachable Coil Market - Further segmented into:
- Bare Platinum Coils
- Coated Coils
- Liquid Embolic Market
Neurovascular Catheter Market - Further segmented into:
- Over-the-Wire Microcatheters
- Flow-Directed Microcatheters
- Neurovascular Guiding Catheters
- Neurovascular Guidewire Market
Neurovascular Stent Market - Further segmented into:
- Traditional Neurovascular Stents
- Flow Diversion Stents
- Intrasaccular Stents
- Balloon Occlusion Device Market
Aneurysm Clip Market - Further segmented into:
- Titanium Clips
- Cobalt Alloy Clips
Neurovascular Thrombus Management Market - Further segmented into:
- Stent Retrievers
- Aspiration Catheters
- Aspiration Pump Canisters
Neuromodulation Device Market - Further segmented into:
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Gastric Electric Stimulation (GES)
- Dorsal Root Ganglion Stimulation (DRG)
- Responsive Neurostimulation Devices
- Intrathecal Pump Market
Stereotactic Device Market - Further segmented into:
- Frame-based Stereotactic Devices
- Frameless Stereotactic Devices
Neuroendoscopy Market - Further segmented into:
- Rigid Endoscopes
- Flexible Endoscopes
- Videoscopes
- Single-Use Endoscopes
- Neuroendoscopic Hand Instruments
- Neuroendoscopy Disposables
Ultrasonic Aspirator Market - Further segmented into:
- Capital Equipment
- Disposable Probe Tips
- Disposable Tubing
- Handpieces
- Accessories
Research Scope Summary
- Regions Covered
- United States
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size & Growth Rates
- Procedure Numbers
- Unit Sales & ASP
- Market Shares & Forecasts through 2031
Qualitative Coverage
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls & Regulatory Developments
- Disruptive Technologies & Emerging Innovations
- Disease Overviews
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- Internal Database
Table of Contents
1. Executive summary
2. U.S. Neurological Device Market Overview
3. Procedure Numbers
4. Cerebrospinal Fluid Management Market
5. Detachable Coil Market
6. Liquid Embolic Market
7. Neurovascular Catheter Market
8. Neurovascular Guidewire Market
9. NEUROVASCULAR STENT Market
10. Balloon Occlusion Device Market
11. Aneurysm Clip Market
12. Neurovascular thrombus Management Market
13. Neuromodulation Device Market
14. Intrathecal Pump Market
15. Stereotactic Device Market
16. Neuroendoscopy Market
17. Ultrasonic ASpirator Market
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- LivaNova
- Acandis
- Medtronic
- Accuracy
- Terumo
- Adeor Medical
- Mizuho
- B Braun
- MRC
- Asahi Intecc
- Natus
- Avanos
- NeuroPace
- Axonics
- Nevro
- Balt
- NICO
- Biosense Webster
- Pentax Medical
- Bioventus
- Penumbra
- Boston Scientific
- Peter Lazic
- Brainlab
- Phenox
- Johnson & Johnson
- Philips
- Cirtec Medical
- Q’apel Medical
- Clarus Medical
- Rapid Medical
- Clearpoint
- Rogue
- Cook Medical
- Saluda Medical
- Dewimed
- Scientia Vascular
- Elekta
- Soering
- Embolx
- Sophysa
- Flowonix
- Stimwave
- Imperative Care
- Stryker
- InoMed
- Teleflex
- Integra LifeSciences
- Tenex Health
- IRRAS
- Varian
- Karl Storz
- Visionsense
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 322 |
Published | March 2024 |
Forecast Period | 2024 - 2031 |
Estimated Market Value ( USD | $ 7.6 Billion |
Forecasted Market Value ( USD | $ 10 Billion |
Compound Annual Growth Rate | 3.8% |
Regions Covered | United States |